Diabetes Drugs
Diabetes Drugs
Diabetes tablets and drugs from Zenomed Healthcare are manufactured in compliance with eGMP certification. We undertake contract manufacturing orders under the name and brand of our customers.
TENELIGLIPTIN TABLETS 20 mg
Each film-coated tablet contains:
Teneligliptin Hydrobromide Hydrate
Equivalent to Teneligliptin 20 mg
GLIMEPIRIDE TABLETS IP 1 mg
Each uncoated tablet contains:
Glimepiride IP 1 mg
GLIMEPIRIDE TABLETS IP 2 mg
Each uncoated tablet contains:
Glimepiride IP 2 mg
VOGLIBOSE TABLETS IP 0.2 mg
Each uncoated tablet contains:
Voglibose IP 0.2 mg
VOGLIBOSE TABLETS IP 0.3 mg
Each uncoated tablet contains:
Voglibose IP 0.3 mg
METFORMIN HYDROCHLORIDE TABLETS IP
Each uncoated tablet contains:
Metformin hydrochloride IP 500 mg
METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS IP
Each uncoated tablet contains:
Metformin Hydrochloride IP 500 mg
Glimepiride IP 1 mg
METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS IP
Each uncoated tablet contains:
Metformin Hydrochloride IP 500 mg
(as prolonged-release)Glimepiride IP 2 mg
METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS 1 Mg
Each uncoated tablet contains:
Metformin Hydrochloride IP 1000 mg
(as prolonged-release)Glimepiride IP 1 mg
METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS - 2 mg
Each uncoated tablet contains:
Metformin Hydrochloride IP 1000 mg
(as prolonged-release)Glimepiride IP 2 mg
METFORMIN HYDROCHLORIDE AND VOGLIBOSE TABLETS
Each uncoated tablet contains:
Metformin Hydrochloride IP 500 mg
(as prolonged- release)Voglibose IP 0.3 mg
GLICLAZIDE MODIFIED RELEASE AND METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS
Each uncoated bi-layered tablet contains:
Gliclazide IP 60 mg
(as modified release)Metformin Hydrochloride IP 500 mg
(Sustained release)
METFORMIN HYDROCHLORIDE AND ALPHA LIPOIC ACID TABLETS
Each film-coated tablet contains:
Metformin Hydrochloride IP 500 mg
Alpha Lipoic Acid USP 200 mg
METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP 1000 mg
Each uncoated prolonged release tablet contains:
Metformin Hydrochloride IP 1000 mg
(as prolonged-release)
OLMESARTAN MEDOXOMIL TABLETS IP 40 mg
Each film-coated tablet contains:
Olmesartan Medoxomil IP 40 mg
NITROGLYCERIN CONTROLLED RELEASE TABLETS
Each uncoated controlled release tablet contains:
Diluted Nitroglycerin IP 2.6 mg
Equivalent to Nitroglycerin
(as controlled release)
PROPRANOLOL HYDROCHLORIDE TABLETS IP 10 mg
Each uncoated tablet contains:
Propranolol Hydrochloride IP 10 mg
PROPRANOLOL HYDROCHLORIDE TABLETS IP 40 mg
Each uncoated tablet contains:
Propranolol Hydrochloride IP 40 mg
PROPRANOLOL HYDROCHLORIDE PROLONGED RELEASE TABLETS 80 mg
Each uncoated prolonged-release contains:
Propranolol Hydrochloride IP 80 mg
(as prolonged-release)
CILNIDIPINE TABLETS IP 5 mg
Each uncoated tablet contains:
Cilnidipine IP 5 mg
CILNIDIPINE TABLETS IP 10 mg
Each uncoated tablet contains:
Cilnidipine IP 10 mg
NEBIVOLOL TABLETS IP 5 mg
Each film-coated tablet contains:
Nebivolol Hydrochloride IP 5 mg
Equivalent to Nebivolol
BENIDIPINE HYDROCHLORIDE TABLETS
Each film-coated tablet contains:
Benidipine Hydrochloride IP 4 mg
BENIDIPINE HYDROCHLORIDE TABLETS
Each film-coated tablet contains:
Benidipine Hydrochloride IP 8 mg
Request for Information
For more information, please fill the form below and we will be in touch.